Protocol for the management of newly diagnosed cases of tuberculosis

World Health Organization, 2018, 1 2018 World Health Organization, 2015, 1 National Strategic Plan for Tuberculosis Elimination 2017–2025, 2017, 5 Peloquin, 2003, What is the ‘right’ dose of rifampin?, Int J Tuberc Lung Dis, 7, 3 Nahid, 2016, Clinical practice guidelines: treatment of drug-susceptible tuberculosis (official American thoracic society/centers for disease control and prevention/infectious diseases society of America), Clin Infect Dis, 63, e147, 10.1093/cid/ciw376 World Health Organization, 2013, xi World Health Organization, 2014, 1 Gordin, 1989, Resumptive diagnosis and treatment of pulmonary tuberculosis based on radiographic findings, Am Rev Respir Dis, 139, 1090, 10.1164/ajrccm/139.5.1090 World Health Organization, 2017, x Liefooghe, 1999, A randomised trial of the impact of counselling on treatment adherence of tuberculosis patients in Sialkot, Pakistan, Int J Tuberc Lung Dis, 3, 1073 Clark, 2007, Effect of pharmacist-led patient education on adherence to tuberculosis treatment, Am J Health Syst Pharm, 64, 497, 10.2146/ajhp050543 M'Imunya, 2012, Patient education and counselling for promoting adherence to treatment for tuberculosis, Cochrane Database Syst Rev, 5 Toman's Tuberculosis Case Detection, 2004, 102 Fox, 1968, The John Barnwell Lecture. Changing concepts in the chemotherapy of pulmonary tuberculosis, Am Rev Respir Dis, 97, 767 Tyrrell, 1956, Bed rest in the treatment of pulmonary tuberculosis, Lancet, 270, 821, 10.1016/S0140-6736(56)91294-6 Hayashi, 2018, Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis, Trop Med Int Health, 23, 1058, 10.1111/tmi.13133 Al-Rifai, 2017, Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis, PLoS One, 21, 10.1371/journal.pone.0187967 Jeon, 2008, Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies, PLoS Med, 5 Lönnroth, 2010, A consistent log-linear relationship between tuberculosis incidence and body mass index, Int J Epidemiol, 39, 149, 10.1093/ije/dyp308 Mitchison, 1965, Chemotherapy of tuberculosis: a bacteriologist's viewpoint, Br Med J, 1, 1333, 10.1136/bmj.1.5446.1333 Canetti, 1964, Host factors and chemotherapy of tuberculosis, 20 2018, 1 Fox, 1980, Short course chemotherapy for tuberculosis, 183 Mitchison, 1985, Mechanisms of the action of drugs in short-course chemotherapy, Bull Int Union against Tuberc Lung Dis, 60, 30 World Health Organization, 2003 Enarson, 2000 Canetti, 1962, The eradication of tuberculosis: theoretical problems and practical solutions, Tubercle, 43, 301, 10.1016/S0041-3879(62)80071-3 World Health Organization, 2010, 1 2003, American thoracic society, center for disease control and prevention, and infectious diseases society of America, MMWR - Treatment of Tuberculosis, 52, 1 Horne, 2010, Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis, Lancet Infect Dis, 10, 387, 10.1016/S1473-3099(10)70071-2 Khan, 2006, Lack of weight gain and relapse risk in a large tuberculosis treatment trial, Am J Respir Crit Care Med, 174, 344, 10.1164/rccm.200511-1834OC Baker, 2011, The impact of diabetes on tuberculosis treatment outcomes: a systematic review, BMC Med, 9, 81, 10.1186/1741-7015-9-81 Wang, 2015, Optimal duration of anti-TB treatment in patients with diabetes: nine or six months?, Chest, 147, 520, 10.1378/chest.14-0918 Leung, 2015, Smoking adversely affects treatment response, outcome and relapse in tuberculosis, Eur Respir J, 45, 738, 10.1183/09031936.00114214 Ahmad Khan, 2012, An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection, Clin Infect Dis, 55, 1154, 10.1093/cid/cis630 Canetti, 1955 1960, A concurrent comparison of isoniazid plus PAS with three regimens of isoniazid alone in the domiciliary treatment of pulmonary tuberculosis in South India, Bull World Health Organ, 23, 535 van Crevel, 2002, Low plasma concentrations of rifampicin in tuberculosis patients in Indonesia, Int J Tuberc Lung Dis, 6, 497, 10.5588/09640569513002 Weiner, 2005, Tuberculosis Trials Consortium. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis, Clin Infect Dis, 40, 1481, 10.1086/429321 Jakko van Ingen, 2011, Andreas H. Diacon, Rodney Dawson, Georgette Plemper van Balen, et al.. Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?, Clin Infect Dis, 52, e194, 10.1093/cid/cir184 Fox, 1999, Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications, Int J Tuberc Lung Dis, 3, S231 World Health Organization, Stop TB department, 2009 Long, 1979, U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis, Am Rev Respir Dis, 119, 879 Kreis, 1976, Two three-month treatment regimens for pulmonary tuberculosis, Bull Int Union Tuberc Lung Dis, 51, 71 Jayaram, 2003, Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis, Antimicrob Agents Chemother, 47, 2118, 10.1128/AAC.47.7.2118-2124.2003 Mitchison, 2000, Role of individual drugs in the chemotherapy of tuberculosis, Int J Tuberc Lung Dis, 4, 796 Peloquin, 2003, What is the ‘right’ dose of rifampin? [Editorial], Int J Tuberc Lung Dis, 7, 3 Diacon, 2007, Early bactericidal activity of high-doserifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears, Antimicrob Agents Chemother, 51, 2994, 10.1128/AAC.01474-06 Mitnick, 2009, Tuberculosis pharmacotherapy: strategies to optimize patient care, Expert Opin Pharmacother, 10, 381, 10.1517/14656560802694564 Egelund, 2015, Optimizing the clinical pharmacology of tuberculosis medications, Clin Pharmacol Ther, 98, 387, 10.1002/cpt.180 Boeree, 2015, PanACEA Consortium. A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis, Am J Respir Crit Care Med, 191, 1058, 10.1164/rccm.201407-1264OC Boeree, 2015, A step toward an optimized rifampin dose completed, Am J Respir Crit Care Med, 192, 525, 10.1164/rccm.201506-1061LE Steingart, 2011, Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review, Int J Tuberc Lung Dis, 15, 305 Peloquin CA, Velásquez GE, Lecca L, Calderón R, Coit J, Pharmacokinetic evidence from the HIRIF trial to support increased doses of rifampin for tuberculosis. Antimicrob Agents Chemother2017; 61. Jindani, 2016, A randomised phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis, Int J Tuberc Lung Dis, 20, 832, 10.5588/ijtld.15.0577 Lesobre, 1969, Jaundice during treatment with rifampicin (12 cases), Rev Tuberc Pneumol (Paris), 33, 393 Saukkonen, 2006, An official ATS statement: hepatotoxicity of antituberculosis therapy, Am J Respir Crit Care Med, 174, 935, 10.1164/rccm.200510-1666ST Yee, 2003, Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis, Am J Respir Crit Care Med, 167, 1472, 10.1164/rccm.200206-626OC Kaona, 2004, An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment, BMC Public Health, 4, 68, 10.1186/1471-2458-4-68 Wares, 2003, Non-adherence to tuberculosis treatment in the eastern Tarai of Nepal, Int J Tuberc Lung Dis, 7, 327 2004 2013 Lin, 2010, Impact of food and antacids on the pharmacokinetics of anti-tuberculosis drugs: systematic review and meta-analysis, Int J Tuberc Lung Dis, 14, 806 Navarro, 2006, Drug-related hepatotoxicity, N Engl J Med, 354, 731, 10.1056/NEJMra052270 Sharma, 2010, Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity, Clin Infect Dis, 50, 833, 10.1086/650576 Chang, 2010, The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debate, Clin Infect Dis, 51, 366, 10.1086/654806 Benator, 2002, Lancet, 360, 528, 10.1016/S0140-6736(02)09742-8 Chang, 2004, A nested case-control study on treatment-related risk factors for early relapse of tuberculosis, Am J Respir Crit Care Med, 170, 1124, 10.1164/rccm.200407-905OC Volmink, 2007, Directly observed therapy for treating tuberculosis, Cochrane Database Syst Rev, CD003343 Karumbi, 2015, Directly observed therapy for treating tuberculosis, Cochrane Database Syst Rev, CD003343 Davidson, 1998, A controlled comparison of directly observed therapy vs self-administered therapy for active tuberculosis in the urban United States, Chest, 114, 1239, 10.1378/chest.114.5.1239